Paul W. Shabram
Chief Tech/Sci/R&D Officer at BIORA THERAPEUTICS, INC.
Paul W. Shabram active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-04-24 | - |
Career history of Paul W. Shabram
Former positions of Paul W. Shabram
| Companies | Position | Start | End |
|---|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Chief Tech/Sci/R&D Officer | - | - |
| Ventana Biosciences, Inc. | Founder | - | - |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2007-06-30 | - |
Training of Paul W. Shabram
| University of California, Santa Cruz | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Technology Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Private companies | 2 |
|---|---|
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
| Ventana Biosciences, Inc. |
- Stock Market
- Insiders
- Paul W. Shabram
- Experience
